Published December 1, 2016 | Version v1
Journal article

MicroRNA as biomarkers of mitochondrial toxicity

  • 1. Department of Toxicology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620 (United States)
  • 2. Department of Pathology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620 (United States)
  • 3. Department of Investigative Toxicology and Pathology, Abbvie, 1 N. Waukegan Rd., North Chicago, IL 60064-6123, USA. (United States)

Description

Mitochondrial toxicity can be difficult to detect as most cells can tolerate reduced activity as long as minimal capacity for function is maintained. However, once minimal capacity is lost, apoptosis or necrosis occurs quickly. Identification of more sensitive, early markers of mitochondrial toxicity was the objective of this work. Rotenone, a mitochondrial complex I inhibitor, and 3-nitropropionic acid (3-NP), a mitochondrial complex II inhibitor, were administered daily to male Sprague–Dawley rats at subcutaneous doses of 0.1 or 0.3 mg/kg/day and intraperitoneal doses of 5 or 10 mg/kg/day, respectively, for 1 week. Samples of kidney, skeletal muscle (quadriceps femoris), and serum were collected for analysis of mitochondrial DNA (mtDNA) copy number and microRNA (miRNA) expression patterns. MtDNA was significantly decreased with administration of rotenone at 0.3 mg/kg/day and 3-NP at 5 and 10 mg/kg/day in the quadriceps femoris and with 3-NP at 10 mg/kg/day in the kidney. Additionally, rotenone and 3-NP treatment produced changes to miRNA expression that were similar in direction (i.e. upregulation, downregulation) to those previously linked to mitochondrial functions, such as mitochondrial damage and biogenesis (miR-122, miR-202-3p); regulation of ATP synthesis, abolished oxidative phosphorylation, and loss of membrane potential due to increased reactive oxygen species (ROS) production (miR-338-5p, miR-546, miR-34c); and mitochondrial DNA damage and depletion (miR-546). These results suggest that miRNAs may be sensitive biomarkers for early detection of mitochondrial toxicity. - Highlights: • MtDNA decreased after treatment with respiratory chain inhibitors rotenone and 3-NP. • Decrease in mtDNA is generally dose-related and indicative of mitochondrial toxicity. • Altered miRNA has reported roles in regulating mitochondrial function. • Induction of miR-338-5p in kidney and serum suggests potential as renal biomarker. • Induction of miR-122 implies that expression may not adhere to liver-specific pattern.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2015.10.007

Additional details

Identifiers

DOI
10.1016/j.taap.2015.10.007;
PII
S0041-008X(15)30110-1;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
312
Journal Page Range
p. 26-33
ISSN
0041-008X
CODEN
TXAPA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49040347
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
APOPTOSIS; ATP; BIOLOGICAL MARKERS; DNA; DNA DAMAGES; DOSES; DRUGS; KIDNEYS; LIVER; MITOCHONDRIA; NECROSIS; OXIDATION; PHOSPHORYLATION; RATS; TOXICITY
Descriptors DEC
ANIMALS; BODY; CELL CONSTITUENTS; CHEMICAL REACTIONS; DIGESTIVE SYSTEM; GLANDS; MAMMALS; NUCLEIC ACIDS; NUCLEOTIDES; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; RODENTS; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.